Pure Biologics Spólka Akcyjna (PUR) — Cash Flow Reinvestment Rate

Latest as of March 2024: 0.05x

Pure Biologics Spólka Akcyjna (PUR) has a Cash Flow Reinvestment Rate of 0.05x as of March 2024, reinvesting zł96.00K (capex zł85.00K plus investments zł-11.00K) from operating cash flow of zł2.04 Million. See PUR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

zł96.00K
Capex + Investments

Operating Cash Flow

zł2.04 Million
PLN

Capital Expenditures

zł85.00K
PLN

Pure Biologics Spólka Akcyjna Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Pure Biologics Spólka Akcyjna across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Pure Biologics Spólka Akcyjna generate cash.

Annual Cash Flow Reinvestment Rate for Pure Biologics Spólka Akcyjna (2019–2019)

Year-by-year capital reinvestment analysis for Pure Biologics Spólka Akcyjna. See how financially flexible is Pure Biologics Spólka Akcyjna to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (PLN) Operating CF Capex YoY Change
2019 5.24x zł27.97 Million zł5.33 Million zł161.92K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow